H. pylori-negative duodenal ulcer prevalence and causes in 774 patients

Digestive Diseases and Sciences

Volumn 44, Issue 11, 1999, Pages 2295-2302

  Gisbert, J P ^a,b   Blanco, M ^a   Mateos, J M ^a   Fernandez Salazar L ^a   Fernandez Bermejo M ^a   Cantero, J ^a   Pajares, J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Playa de Mojacar   (Spain)

Author keywords

Antibiotics; Duodenal ulcer; Helicobacter pylori; Nonsteroidal antiinflammatory drugs; Omeprazole; Peptic ulcer; Proton pump inhibitor

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0032705677     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026669123593     Document Type: Article

References (71)

1. 1. Kuipers EJ, Thijs JC, Festen HPM: The prevalence of H. pylori in peptic ulcer disease. Aliment Pharmacol Ther 9(suppl 2):59-69, 1995
2. 2. Gisbert JP, Boixeda D, Martin de Argila C: Helicobacter pylori and duodenal ulcer: A causal relation or mere association? Rev Clin Esp 197:693-702, 1997
3. 3. Jyothecswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY: Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: Is empirical triple therapy justified? Am J Gastroenterol 93:574-578, 1998
4. 4. Sprung DJ, Apter M, Allen B, Cook L, Allen B, Guarda L: The prevalence of Helicobacter pylori in duodenal ulcer disease: A community based study. Am J Gastroenterol 91:1926 (AI69), 1996 (abstract)
5. 5. Gislason GT, Emu B, Okolo III, Pasricha PJ, Kalloo AN: Where have all the Helicobacter pylori gone? Etiologic factors in patients with duodenal ulcers presenting to a university hospital. Gastrointest Endosc 45:263, 1997 (abstract)
6. 6. Nensey YW, Schubert TT, Bologna SD, Ma CK: Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 91:15-18, 1991
7. 7. Booth L, Holdstock G, MacBridge H, Hawtin P, Gibson JR, Ireland A, Bamforth J, DuBoulay CE, Lloyd RS, Pearson AD: Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol 39:215-219, 1986
8. 8. Greenherg PD, Koch J, Cello JP: Clinical utility and cost effectiveness of H. pylori testing for patients with duodenal and gastric ulcers. Am J Gastroenterol 91:228-232, 1996
9. 9. Von Wulffen H, Heesemann J, Butzow GH, Loning T, Laufs R: Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol 24:716-719, 1986
10. 10. Fiocca R, Villani L, Turpini F: High incidence of Campylobacter-like organism in endoscopic biopsies from patients with gastritis with or without peptic ulcer. Digestion 38:234-237, 1987
11. 11. Andersen LP, Elsborg L, Justesen T: Campylobacter pylori in peptic ulcer disease. Scand J Gastroenterol 23:760-764, 1988
12. 12. Kang JY, Wee A: H. pylori and gastric acid output in peptic ulcer disease. Dig Dis Sci 36:5-9, 1991
13. 13. Prach AT, Senior BW, Hopwood D, McBride PD, MacDonald TM, Kerr MA, Murray FE: H. pylori infection status in relation to antibiotic and non-steroidal prescribing in patients on maintenance treatment for chronic duodenal ulcer. Eur J Gastroenterol Hepatol 9:251-256, 1997
14. 14. Gisbert JP, Boixeda D, Redondo C, Alvarez Baleriola I, Jimenez I, Ferez Garcia JI, Pajares JM: Breath test in the diagnosis of Helicobacter pylori infection: Concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa. Rev Esp Enferm Dig 88:259-264, 1996
15. 15. Gisbert JP, Boixeda D, Vila T, De Rafael L, Alvarez Baleriola I, Martin de Argila C: Decrease of basal and stimulated gastrin levels: A useful non-invasive method for checking Helicobacter pylori eradication after therapy. Gastroenterol Int 8:8-16, 1995
16. 16. Gisbert JP, Boixeda D, Vila T, de Rafael L, Redondo C, Canton R, Martin de Argila C: Verification of decreased basal and stimulated serum pepsinogen I levels is a useful noninvasive method for determining the success of eradication therapy on Helicobacter pylori. Scand J Gastroenterol 31:103-110, 1996
17. 17. Hill AB: The environment and disease: Association or causation. Proc R Soc Med 58:295-299, 1965
18. 18. Di Battista R, Bierti L, Benassi R, Bortoli A, Ferrara A, Redaelli D, Spinzi G, Meucci G, Venturelly R, de Franchis R: Prevalence and risk factors in H. pylori peptic ulcer in an area of northern Italy. Gut 41(suppl 1):A38, 1997 (abstract)
19. 19. Marshall BJ, Warren JR: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275, 1983
20. 20. McBride PD, MacDonald TM, Kerr MA: Campylobacter pyloridis and epigastric pain: Endoscopic, histological, and bacterial correlations. Gastroenterol Clin Biol 11:212-216, 1987
21. 21. Hui WM, Lam SK, Chau PY, Ho J, Lui I, Lai CL, Lok AS, Ng MM: Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 32:1255-1260, 1987
22. 22. Feng YY, Wang Y: Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China. Lancet i:1055-1056, 1988
23. 23. Humphreys H, Bourke S, Dooley C, McKenna D, Power B, Keane CT, Sweeney EC, O'Morain C: Effect of treatment on Campylobacter pylori in peptic disease: A randomised prospective trial. Gut 29:279-283, 1988
24. 24. Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615-625, 1989
25. 25. Dooley CP, McKenna D, Humphreys H, Bourke S, Keane CT, Sweeney E, O'Morain C: Histological gastritis in duodenal ulcer: Relationship to Campylobacter pylori and effect of ulcer therapy. Am J Gastroenterol 83:278-282, 1988
26. 26. Johnston BJ, Reed PI, Ali MH: Prevalence of Campylobacter pylori in duodenal and gastric mucosa. Relationship to inflammation. Scand J Gastroenterol 23(suppl 142):69-75, 1988
27. 27. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN: Campylobacter pyloridis-associated chronic active antral gastritis: A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33-40, 1988
28. 28. Gad A, Hradsky M, Furugard K, Malmodin B, Nyberg O: Campylobacter pylori and gastroduodenal ulcer disease. A prospective study in a Swedish population. Scand J Gastroenterol 24(suppl 167):81-85, 1989
29. 29. Britt AP, Barakat MH, Tungckar MF, Painchaud SM, Adlouni M, Kern K, Malhas L: H. pylori in dyspeptic patients in Kuwait. J Clin Pathol 43:987-991, 1990
30. 30. Carrick J, Lee A, Hazell S, Ralston M, Daskalopoulos G: Campylobacter pylori, duodenal ulcer and gastric metaplasia: Possible role of functional heterotopic tissue in ulcerogenesis. Gut 30:790-797, 1989
31. 31. Blaser MJ, Pérez-Pérez GI, Linderbaum J, Schneidman D, Van Deventer G, Marin-Sorensen M, Weinstein WM: Association of infection due to H. pylori with specific upper gastrointestinal pathology. Rev Infect Dis 13(suppl 8):S704-S707, 1991
32. 32. Borody TJ, George LL, Brandl S, Andrews P, Ostapowicz N, Hyland L, Devine M. H. pylori-negative duodenal ulcer. Am J Gastroenterol 86:1154-1157, 1991
33. 33. Fiocca R, Villani L, Luinetti O, Gianatti A, Perego M, Alvisi C, Turpini F, Solcia E: Helicobacter colonization and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: A morphological approach to the study of ulcerogenesis in man. Virchows Arch A Pathol Anal 420:489-498, 1992
34. 34. Valle J, Pikkarainen P, Vuoristo M, Sipponen P, Kekki M, Siurala M: H. pylori and duodenal ulcer. A study of duodenal ulcer patients and their first-degree relatives. Scand J Gastroenterol 26(suppl 186):45-51, 1991
35. 35. Tytgat GNJ, Axon ATR, Dixon MF: H. pylori: Causal agent in peptic ulcer disease? Working Party Reports, Sydney, p 36, 1990
36. 36. Peterson WL, Barnett CC, Evans DJ, Feldman M, Carmody T, Richardson C, Walsh J, Graham DY: Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: The role of H. pylori. Am J Gastroenterol 88:2038-2043, 1993
37. 37. Louw JA, Falck V, Van Rensburg C, Zak J, Adams G, Marks IN: Distribution of H. pylori colonisation and associated gastric inflammatory changes: Difference between patients with duodenal and gastric ulcers. J Clin Pathol 46:754-756, 1993
38. 38. Al-Assi MT, Genta RM, Karttunen TJ, Graham DY: Ulcer site and complications: Relation to Helicobacter pylori infection and NSAID use. Endoscopy 28:229-233, 1996
39. 39. Hyvarinen H, Salmenkyla S, Sipponen P: Helicobacter pylori-negative duodenal and pyloric ulcer: Role of NSAIDs. Digestion 57:305-309, 1996
40. 40. McColl KEL, El-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, El-Omar E, Penman I, Fitzsimons EJ, Drain J, Graham H: A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 34:762-768, 1993
41. 41. Lanza FL: A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 93:2037-2046, 1998
42. 42. Luthra GK, DiNuzzo AR, Gourley WK, Crowe SE: Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics. Am J Gastroenterol 93:1291-1296, 1998
43. 43. Weil J, Bell GD, Powell K: Omeprazole and H. pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther 5:303-313, 1991
44. 44. Logan RPH, Walker MM, Misicwicz JJ, Gummett PA, Karim QN, Baron JH: Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36:12-16, 1995
45. 14C-urea breath test. Am J Gastroenterol 91:89-92, 1996
46. 46. Daw MA, Deegan P, Leen E, O'Morain C: Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther 5:435-439, 1991
47. 47. Hui WM, Lam SK, Ho J, Lai CL, Lok AS, Ng MM, Lau WY, Branicki FJ: Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 36:577-582, 1991
48. 48. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty B: Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 129:547-550, 1998
49. 13C-urea breath test results. Am J Gastroenterol 93:1297-1299, 1998
50. 14C-urea breath test by a pH-dependent mechanism. Am J Gastroenterol 92:446-450, 1997
51. 51. Bayerdörffer E, Oerterl H, Lehn H, Kasper G, Mannes GA, Sauerbruch T, Stolte M: Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 42:834-839, 1989
52. 52. Genta RM, Graham DY: Comparison of biopsy sites for histopathologic diagnosis of H. pylori: A topographic study of H. pylori density and distribution. Gastrointest Endosc 40:342-345, 1994
53. 53. Guidelines for clinical trials in H. pylori infection. Technical annex: Test used to assess H. pylori infection. Gut 41(suppl 2):S10-S18, 1997
54. 54. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161-1181, 1996
55. 55. Boixeda D, Gisbert JP, De Rafael L, Alvarez Baleriola I, Martin de Argila C, Bermejo F, Garcia Plaza A: The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori. Med Clin (Barc) 105:566-569, 1995
56. 56. Sonnenberg A, Muller-Lissner SA, Vogel E, Schmid P, Gonvers JJ, Peter P, Strohmeyer G, Blum AL: Predictors of DU healing and relapse. Gastroenterology 81:1061-1067, 1981
57. 57. Sonnenberg A, Townsend WF: Testing for H. pylori in the diagnosis of Zollinger-Ellison syndrome. Am J Gastroenterol 86:606-608, 1991
58. 58. Gisbert JP, Boixeda D, Vila T, Canton R, Alvarez Baleriola I, Defarges V, Martin de Argila C: Helicobacter pylori infection and basal levels of serum gastrin in patients with duodenal ulcer and subjects with normal endoscopy. Med Clin (Barc) 106:325-328, 1996
59. 59. Rotter JI, Sones JQ, Samloff M, Richardson CT, Gursky JM, Walsh JH, Rimoin DI.: Duodenal ulcer disease associated with elevated serum pepsinogen I. N Engl J Med 300:63-66, 1979
60. 60. Chittajallu RS, Dorrian CA, Ardill JES, McColl KEL: Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 27:20-24, 1992
61. 61. Gisbert JP, Boixeda D, Vila T, de Rafael L, Redondo C, Martin de Argila C, Arocena C: Basal pepsinogen I levels and Helicobacter pylori infection in patients with duodenal ulcer and normal endoscopy. Rev Esp Enferm Dig 88:3-8, 1996
62. 62. Pounder R: Duodenal ulcers that are difficult to heal. Br Med J 297:1560-1561, 1988
63. 63. Lanas A, Remacha B, Esteva F, Sainz R: Risk factors associated with refractory peptic ulcers. Gastroenterology 109:1124-1133, 1995
64. 64. NIH Consensus Development Panel on H. pylori in Peptic Ulcer Disease: H. pylori in peptic ulcer disease. JAMA 272:65-69, 1994
65. 65. Sonnenberg A, Townsend WF: Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med 155:922-928, 1995
66. 66. Imperiale TF, Speroff T, Cebul RD, McCullough AJ: A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med 123:665-672, 1995
67. 67. Feldman M: The acid test. Making clinical sense of the Consensus Conference on Helicobacter pylori. JAMA 272:70-71, 1994 (editorial)
68. 68. Massuda HK, Boyd EJS: Who should undergo testing tor Helicobacter pylori Am J Gastroenterol 91:1070-1071, 1996 (editorial)
69. 69. Lee J, O'Morain C: Who should be treated for Helicobacter pylori infection? A review of Consensus Conferences and Guidelines. Gastroenterology 113:S99-S106, 1997
70. 70. Isenberg JI, McQuaid KR, Laine L, Walsh JH: Acid-peptic disorders. In Textbook of Gastroenterology, Vol. 1. T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein, (eds.). Philadelphia, JB Lippincott, 1995, pp 1347-1430
71. 71. Graham DY: Patients, payers, and paradigm shifts: What to do about H. pylori. Am J Gastroenterol 91:188-190, 1996